March 19, 2020
More than a dozen Japanese pharmaceutical companies have provided their APIs to the National Institute of Infectious Diseases (NIID) for its screening aimed at identifying potential treatments for the novel coronavirus disease COVID-19, an industry survey showed. According to the...read more